Lieto M, Roca A, Santorelli FM, Fico T, De Michele G, Bellofatto M, Saccà F, De Michele G, Filla A. Degenerative and acquired sporadic adult onset ataxia. Neurol Sci. 2019;40(7):1335–42. https://doi.org/10.1007/s10072-019-03856-w.

Article  PubMed  Google Scholar 

Berciano J, Gazulla J, Infante J. History of ataxias and paraplegias with an annotation on the first description of striatonigral degeneration. Cerebellum. 2022;21(4):531–44. https://doi.org/10.1007/s12311-021-01328-6.

Article  PubMed  Google Scholar 

Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci. 2007;30:575–621. https://doi.org/10.1146/annurev.neuro.29.051605.113042.

Article  CAS  PubMed  Google Scholar 

Mongelli A, Magri S, Salvatore E, Rizzo E, De Rosa A, Fico T, Gatti M, Gellera C, Taroni F, Mariotti C, Nanetti L. Frequency and distribution of polyQ disease intermediate-length repeat alleles in healthy Italian population. Neurol Sci. 2020;41(6):1475–82.

Article  PubMed  Google Scholar 

Gardiner SL, Boogaard MW, Trompet S, de Mutsert R, Rosendaal FR, Gussekloo J, Jukema JW, Roos RAC, Aziz NA. Prevalence of carriers of intermediate and pathological polyglutamine disease-associated alleles among large population-based cohorts. JAMA Neurol. 2019;76(6):650–6. https://doi.org/10.1001/jamaneurol.2019.0423.

Article  PubMed  Google Scholar 

Mongelli A, Sarro L, Rizzo E, Nanetti L, Meucci N, Pezzoli G, Goldwurm S, Taroni F, Mariotti C, Gellera C. Multiple system atrophy and CAG repeat length: a genetic screening of polyglutamine disease genes in Italian patients. Neurosci Lett. 2018;678:37–42. https://doi.org/10.1016/j.neulet.2018.04.044.

Article  CAS  PubMed  Google Scholar 

Sproviero W, Shatunov A, Stahl D, Shoai M, van Rheenen W, Jones AR, Al-Sarraj S, Andersen PM, Bonini NM, Conforti FL, Van Damme P, Daoud H, Del Mar AM, Fogh I, Forzan M, Gaastra B, Gellera C, Gitler AD, Hardy J, Fratta P, La Bella V, Le Ber I, Van Langenhove T, Lattante S, Lee YC, Malaspina A, Meininger V, Millecamps S, Orrell R, Rademakers R, Robberecht W, Rouleau G, Ross OA, Salachas F, Sidle K, Smith BN, Soong BW, Sorarù G, Stevanin G, Kabashi E, Troakes C, van Broeckhoven C, Veldink JH, van den Berg LH, Shaw CE, Powell JF, Al-Chalabi A. ATXN2 trinucleotide repeat length correlates with risk of ALS. Neurobiol Aging. 2017;51:178.e1-178.e9. https://doi.org/10.1016/j.neurobiolaging.2016.11.010.

Article  CAS  PubMed  Google Scholar 

GhahremaniNezhad H, Franklin JP, Alix JJP, Moll T, Pattrick M, Cooper-Knock J, Shanmugarajah P, Beauchamp NJ, Hadjivissiliou M, Paling D, Mcdermott C, Shaw PJ, Jenkins TM. Simultaneous ALS and SCA2 associated with an intermediate-length ATXN2 CAG-repeat expansion. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22(7–8):579–82. https://doi.org/10.1080/21678421.2020.1853172.

Article  Google Scholar 

Rubino E, Mancini C, Boschi S, Ferrero P, Ferrone M, Bianca S, Zucca M, Orsi L, Pinessi L, Govone F, Vacca A, Gai A, Giordana MT, Brusco A, Rainero I. ATXN2 intermediate repeat expansions influence the clinical phenotype in frontotemporal dementia. Neurobiol Aging. 2019;73(231):e7-231.e9. https://doi.org/10.1016/j.neurobiolaging.2018.09.009.

Article  CAS  Google Scholar 

Samukawa M, Hirano M, Saigoh K, Kawai S, Hamada Y, Takahashi D, Nakamura Y, Kusunoki S. PSP-phenotype in SCA8: case report and systemic review. Cerebellum. 2019;18(1):76–84. https://doi.org/10.1007/s12311-018-0955-0.

Article  CAS  PubMed  Google Scholar 

Munhoz RP, Teive HA, Raskin S, Troiano AR. Atypical parkinsonism and SCA8. Parkinsonism Relat Disord. 2006;12(3):191–2. https://doi.org/10.1016/j.parkreldis.2005.10.001.

Article  PubMed  Google Scholar 

Hall D, Tassone F, Klepitskaya O, Leehey M. Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers. Mov Disord. 2012;27(2):296–300. https://doi.org/10.1002/mds.24021.

Article  CAS  PubMed  Google Scholar 

Hall DA, Nag S, Ouyang B, Bennett DA, Liu Y, Ali A, Zhou L, Berry-Kravis E. Fragile X gray zone alleles are associated with signs of Parkinsonism and earlier death. Mov Disord. 2020;35(8):1448–56. https://doi.org/10.1002/mds.28086.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hall DA, Berry-Kravis E, Zhang W, Tassone F, Spector E, Zerbe G, Hagerman PJ, Ouyang B, Leehey MA. FMR1 gray-zone alleles: association with Parkinson’s disease in women? Mov Disord. 2011;26(10):1900–6. https://doi.org/10.1002/mds.23755.

Article  PubMed  PubMed Central  Google Scholar 

Loesch DZ, Khaniani MS, Slater HR, Rubio JP, Bui QM, Kotschet K, D’Souza W, Venn A, Kalitsis P, Choo AK, Burgess T, Johnson L, Evans A, Horne M. Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism. Clin Genet. 2009;76(5):471–6. https://doi.org/10.1111/j.1399-0004.2009.01275.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Loesch DZ, Tassone F, Mellick GD, Horne M, Rubio JP, Bui MQ, Francis D, Storey E. Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females. Mov Disord. 2018;33(7):1178–81. https://doi.org/10.1002/mds.27420.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Winarni TI, Zhang L, Tassone F, Hagerman RJ. Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers. Clin Genet. 2013;84(1):74–7. https://doi.org/10.1111/cge.12026.

Article  CAS  PubMed  Google Scholar 

Debrey SM, Leehey MA, Klepitskaya O, Filley CM, Shah RC, Kluger B, Berry-Kravis E, Spector E, Tassone F, Hall DA. Clinical phenotype of adult fragile X gray zone allele carriers: a case series. Cerebellum. 2016;15(5):623–31. https://doi.org/10.1007/s12311-016-0809-6.

Article  PubMed  Google Scholar 

Factor SA, Qian J, Lava NS, Hubbard JD, Payami H. False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy. Ann Neurol. 2005;57(3):462–3. https://doi.org/10.1002/ana.20389.

Article  PubMed  Google Scholar 

Alvarez-Mora MI, Madrigal I, Martinez F, Tejada MI, Izquierdo-Alvarez S, Sanchez-Villar de Saz P, Caro-Llopis A, Villate O, Rodríguez-Santiago B, Pérez Jurado LA, Rodriguez-Revenga L, Milà M. Clinical implication of FMR1 intermediate alleles in a Spanish population. Clin Genet. 2018;94(1):153–8. https://doi.org/10.1111/cge.13257.

Article  CAS  PubMed  Google Scholar 

Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Schöls L, Szymanski S, van de Warrenburg BP, Dürr A, Klockgether T, Fancellu R. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717–20 (Erratum in: Neurology. 2006 Jul 25;67(2):299. Fancellu, Roberto [added]).

Article  PubMed  Google Scholar 

de Silva R, Greenfield J, Cook A, Bonney H, Vallortigara J, Hunt B, Giunti P. Guidelines on the diagnosis and management of the progressive ataxias. Orphanet J Rare Dis. 2019;14(1):51. https://doi.org/10.1186/s13023-019-1013-9.

Article  PubMed  PubMed Central  Google Scholar 

van de Warrenburg BP, van Gaalen J, Boesch S, Burgunder JM, Dürr A, Giunti P, Klockgether T, Mariotti C, Pandolfo M, Riess O. EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood. Eur J Neurol. 2014;21(4):552–62. https://doi.org/10.1111/ene.12341.

Article  PubMed  Google Scholar 

Folstein MF. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98. https://doi.org/10.1016/0022-3956(75)90026-6.

Article  CAS  PubMed  Google Scholar 

Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Dürr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71(9):670–6. https://doi.org/10.1212/01.wnl.0000324625.00404.15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szmulewicz DJ, Roberts L, McLean CA, MacDougall HG, Halmagyi GM, Storey E. Proposed diagnostic criteria for cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Neurol Clin Pract. 2016;6(1):61–8. https://doi.org/10.1212/CPJ.0000000000000215.

Article  PubMed  PubMed Central  Google Scholar 

Den Dunnen WFA. Trinucleotide repeat disorders. Handb Clin Neurol. 2017;145:383–91. https://doi.org/10.1016/B978-0-12-802395-2.00027-4.

Article  Google Scholar 

O’Hearn E, Holmes SE, Margolis RL. Spinocerebellar ataxia type 12. Handb Clin Neurol. 2012;103:535–47. https://doi.org/10.1016/B978-0-444-51892-7.00034-6.

Article  PubMed  Google Scholar 

Kronquist KE, Sherman SL, Spector EB. Clinical significance of tri-nucleotide repeats in Fragile X testing: a clarification of American College of Medical Genetics guidelines. Genet Med. 2008;10(11):845–7. https://doi.org/10.1097/GIM.0b013e31818b0c8a.

Article  PubMed  PubMed Central  Google Scholar 

Sequeiros J, Seneca S, Martindale J. Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias. Eur J Hum Genet. 2010;18(11):1188–95. https://doi.org/10.1038/ejhg.2010.10.

Article  PubMed  PubMed Central  Google Scholar 

Laffita-Mesa JM, Velázquez-Pérez LC, Santos Falcón N, Cruz-Mariño T, González Zaldívar Y, Vázquez Mojena Y, Almaguer-Gotay D, AlmaguerMederos LE, Rodríguez Labrada R. Unexpanded and intermediate CAG polymorphisms at the SCA2 locus (ATXN2) in the Cuban population: evidence about the origin of expanded SCA2 alleles. Eur J Hum Genet. 2012;20(1):41–9. https://doi.org/10.1038/ejhg.2011.154.

Article  CAS  PubMed  Google Scholar 

Klockgether T. Sporadic adult-onset ataxia. Handb Clin Neurol. 2018;155:217–25.